Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24770325.
- Also identified by DOI 10.1038/nbt.2908 and PMC identifier 4090141.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Monomeric CRISPR-Cas9 nucleases are widely used for targeted genome editing but can induce unwanted off-target mutations with high frequencies. Here we describe dimeric RNA-guided FokI nucleases (RFNs) that can recognize extended sequences and edit endogenous genes with high efficiencies in human cells. RFN cleavage activity depends strictly on the binding of two guide RNAs (gRNAs) to DNA with a defined spacing and orientation substantially reducing the likelihood that a suitable target site will occur more than once in the genome and therefore improving specificities relative to wild-type Cas9 monomers. RFNs guided by a single gRNA generally induce lower levels of unwanted mutations than matched monomeric Cas9 nickases. In addition, we describe a simple method for expressing multiple gRNAs bearing any 5' end nucleotide, which gives dimeric RFNs a broad targeting range. RFNs combine the ease of RNA-based targeting with the specificity enhancement inherent to dimerization and are likely to be useful in applications that require highly precise genome editing.
Medical subject headings
- Bacterial Proteins
- CRISPR-Cas Systems
- Deoxyribonucleases, Type II Site-Specific
- Endonucleases
- Gene Editing
- Recombinant Fusion Proteins